# LG AI Research — LG AI Research and D&D Pharmatech Partner to Advance AI-Powered Next-Generation Peptide Drug Discovery

- Company: LG AI Research (lgresearch.ai)
- Announced: 2026-06-17
- Category: partnership-acquisition
- Coverage: not counted
- Announcement: yes
- Group: announcements
- Source: https://www.lgresearch.ai/news/view?seq=657
- Record: https://forck.live/items/10990-lg-ai-research-and-d-d-pharmatech-partner-to-advance-ai-powered-next
- Subject: EXAONE

LG AI Research and D&D Pharmatech signed a definitive agreement to jointly develop next-generation peptide therapeutics. LG AI Research will design drug candidates using AI, while D&D Pharmatech will handle validation, clinical development, and regulatory approval. The collaboration aims to reduce development timelines and costs while improving clinical success probability.

## Evidence

Verbatim from https://www.lgresearch.ai/news/view?seq=657:

> Under this agreement, the two companies will collaborate to develop innovative therapeutics for hard-to-treat diseases and precision medicine, leveraging AI-driven drug discovery and oral delivery technologies.

---

Record: https://forck.live/items/10990-lg-ai-research-and-d-d-pharmatech-partner-to-advance-ai-powered-next
Catalogue: https://forck.live/llms.txt
Current issue: https://forck.live/feed.md
